---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-005408"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:41:31.473968+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Journey Medical CFO resigns; Corporate Controller Benesch named interim CFO effective Jan 27.

## Summary
- Ernest De Paolantonio resigns as CFO effective Jan 27, 2023; will consult through March 31, 2023.
- Joseph Benesch, Corporate Controller since Nov 2021, appointed interim CFO effective Jan 27, 2023.
- Benesch has over 25 years of finance experience, is a CPA, and previously held senior roles at Teligent and Torrent.
- No immediate change to Benesch's compensation; search for permanent CFO underway internally and externally.

## SEC filing metadata
- accession: 0001104659-23-005408
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/tm234058d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-005408
- JSON: https://secwatch.observer/filing/0001104659-23-005408.json
- Plain text: https://secwatch.observer/filing/0001104659-23-005408.txt

## Key facts
- Executive change
  Ernest De Paolantonio resigned as Chief Financial Officer at Journey Medical Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 16, 2023, Ernest De Paolantonio, the Chief Financial Officer of Journey Medical Corporation (the “ Company ”) provided notice to the Company of his resignation, effective January 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm
- Executive change
  Joseph Benesch was appointed as interim Chief Financial Officer at Journey Medical Corp.
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: Joseph Benesch, age 56, the Company’s Corporate Controller, was appointed as the Company’s interim Chief Financial Officer, effective January 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.